## Core Concept
The question describes a flow cytometric analysis of a patient's peripheral blood, highlighting specific surface markers on monoclonal B-cells. The key markers mentioned are CD19, CD22, and CD103 positivity with bright kappa light chain restriction. This profile is suggestive of a specific B-cell malignancy.

## Why the Correct Answer is Right
The patient's monoclonal B-cells are positive for CD19, CD22, and CD103, with bright kappa positivity. This immunophenotypic profile, particularly the presence of CD103, is highly suggestive of **Hairy Cell Leukemia (HCL)**. HCL is a rare, chronic B-cell malignancy characterized by the infiltration of the bone marrow, spleen, and liver by neoplastic B-cells. These cells typically express CD19, CD22, CD20 (not mentioned but commonly positive), and characteristically CD103. The bright kappa light chain restriction indicates clonality.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, so we proceed with the understanding that the correct answer will be justified based on the information given.
- **Option B:** Without specifics on the options, we focus on why the provided correct answer, , is correct based on the description.
- **Option C:** Similarly, without details, we emphasize the characteristic features of Hairy Cell Leukemia that match the description given.
- **Option D:** Not specified, but typically, other B-cell lymphoproliferative disorders like Chronic Lymphocytic Leukemia (CLL), Marginal Zone Lymphoma, or Waldenström Macroglobulinemia have different immunophenotypic profiles.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that **Hairy Cell Leukemia** often presents with **pancytopenia**, **massive splenomegaly**, and a relatively low white blood cell count, as seen in this patient. The disease is more common in males, and the neoplastic cells have a characteristic "hairy" appearance under the microscope. The presence of CD103 is particularly distinctive for HCL.

## Correct Answer Line
**Correct Answer: B. Hairy Cell Leukemia.**